Evidence map›Paper›PMID 36927720›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2023

Environmental surveillance of antimicrobial resistance (AMR), perspectives from a national environmental regulator in 2023.

Alwyn Hart, Jonathan Warren, Helen Wilkinson, Wiebke Schmidt

Open access · diamondFull text read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Antimicrobial-resistantmedRxiv : the preprint server for health sciences · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Culture, qPCR, and genome-based surveillance ofFrontiers in microbiology · 2026
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Agriculturally Sourced Multidrug-ResistantPathogens (Basel, Switzerland) · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alwyn HartEnvironment Agency, Horizon House, Deanery Road, Bristol, United Kingdom.
Jonathan WarrenEnvironment Agency, Horizon House, Deanery Road, Bristol, United Kingdom.
Helen WilkinsonEnvironment Agency, Horizon House, Deanery Road, Bristol, United Kingdom.
Wiebke SchmidtEnvironment Agency, Horizon House, Deanery Road, Bristol, United Kingdom.
Environment Agency · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development, and in some cases increasing prevalence, of resistance to antimicrobials used in clinical and veterinary settings has long been recognised. In recent years, the concept of 'One Health' has added recognition of the role that the environment plays in health protection along with the need for protection of the health of the environment itself. Organisations including the World Health Organization, United Nations Environment Programme, and national governments have identified a need for surveillance of antimicrobial resistance in the environment to sit alongside the surveillance carried out in clinical, veterinary and food sectors. However, having recognised the need for environmental surveillance there are multiple challenges in deciding what this should entail. For example, what pathogens or genes to monitor, who or what we wish to protect and what measures we wish to enable to decrease infection risks. That might include sampling near a source of resistant organisms entering the environment or conversely sampling where the exposure actually occurs. Choices need to be made at both policy and technical levels based on the detailed purposes of surveillance. This paper discusses these issues from the perspective of a national environmental regulator.

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsDrug Resistance, BacterialEnvironmental MonitoringHumansWorld Health OrganizationAnti-Bacterial AgentsAnti-Infective AgentsAMRAntimicrobial resistanceEnvironmentMethodMonitoringOne HealthSurveillance

Identifiers

PMID36927720
PMCPMC10021475
OpenAlexW4327681915

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read1
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.